Large market potential Velos serves 2,000+ research sites across hospitals, health systems, and research organizations including 43 cancer centers and 20 NCI-designated centers, indicating a broad customer base and multiple expansion opportunities within large R&D networks.

Clinical trial footprint With over 30,000 clinical studies and more than half a million subject data points managed through Velos eResearch, there is potential to upsell advanced analytics, data quality tooling, or integration enhancements to optimize study operations.

Private company momentum Privately held since 1996 with a mid-size employee base and reported revenue in the 25–50 million range, Velos presents a scalable platform opportunity for growth-focused buyers seeking cost efficiency and configurable workflows.

Strategic partnerships Historical partner activity, including collaborations with professional services, analytics platforms, and webinar initiatives, suggests room to formalize co-sell arrangements or expand integration ecosystems with research IT, CROs, and academic medical centers.

Technology and compliance fit Velos’ web-based, configurable CRMS and emphasis on data quality align with needs for interoperability, regulatory compliance, and streamlined financial, administrative, and clinical workflows—ideal for hospitals and research centers pursuing efficiency gains.